677469
Titanium dioxide
contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
Sinónimos:
Dióxido de titanio, Titania
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
TiO2
Número CAS:
Peso molecular:
79.87
UNSPSC Code:
12352302
PubChem Substance ID:
NACRES:
NA.23
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Óxido de titanio (IV), contains 1% Mn as dopant, nanopowder, <100 nm particle size (BET), ≥97%
Quality Level
assay
≥97%
form
nanopowder
contains
1% Mn as dopant
reaction suitability
reagent type: catalyst
core: titanium
surface area
>14.0 m2/g
particle size
<100 nm (BET)
mp
>350 °C (lit.)
density
4.26 g/mL at 25 °C (lit.)
SMILES string
O=[Ti]=O
InChI
1S/2O.Ti
InChI key
GWEVSGVZZGPLCZ-UHFFFAOYSA-N
Application
Titanium dioxide nanopowder was used to generate light scattering tissue phantoms. Its effect on the development of Xenopus laevis was also investigated. Titania nanopowder may be used for coating as well.
Legal Information
Product of Engi-Mat Co.
Still not finding the right product?
Explore all of our products under Óxido de titanio (IV)
Clase de almacenamiento
13 - Non Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Synthesis of ZnO Aggregates and Their Application in Dye-sensitized Solar Cells
Qifeng Z, et al.
Material Matters, 5(2), 32-32 (2010)
Renato Bacchetta et al.
Nanotoxicology, 6(4), 381-398 (2011-05-18)
The teratogenic potential of commercially available copper oxide (CuO), titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles (NPs) was evaluated using the standardized FETAX test. After characterization of NP suspensions by TEM, DLS and AAS, histopathological screening and advanced confocal
Joshua K Meisner et al.
Microcirculation (New York, N.Y. : 1994), 19(7), 619-631 (2012-05-18)
1) To develop and validate laser speckle flowmetry (LSF) as a quantitative tool for individual microvessel hemodynamics in large networks. 2) To use LSF to determine if structural differences in the dorsal skinfold microcirculation (DSFWC) of C57BL/6 and BALB/c mice